The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Interferons and Their Stimulated Genes in the Tumor Microenvironment
Open accessAbstract
Constitutive expression of interferons (IFNs) and activation of their signaling pathways have pivotal roles in host responses to malignant cells in the tumor microenvironment. IFNs are induced from the innate immune system and in tumors through stimulation of Toll-like receptors (TLRs) and through other signaling pathways in response to specific cytokines. Although in the oncologic context IFNs have been thought of more as exogenous pharmaceuticals, the autocrine and paracrine actions of endogenous IFNs probably have even more critical effects on neoplastic disease outcomes. Through high-affinity cell surface receptors, IFNs modulate transcriptional signaling, leading to regulation of over 2000 genes with varying patterns of temporal expression. Induction of the gene products by both unphosphorylated and phosphorylated STAT1 after ligand binding, results in alterations in tumor cell survival, inhibition of angiogenesis, and augmentation of actions of T, natural killer (NK), and dendritic cells. The interferon-stimulated gene (ISG) signature can be a favorable biomarker of immune response but, in a seemingly paradoxical finding, a specific subset of the full ISG signature indicates an unfavorable response to DNA damaging interventions such as radiation. IFNs in the tumor microenvironment thus can alter the emergence, progression, and regression of malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage
Townsend, P. A., Cragg, M. S., Davidson, S. M., McCormick, J., Barry, S. P., Lawrence, K. M., Knight, R. A., Hubank, M. J. F., Chen, P., Latchman, D. S., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.01728 · Cited by 69
RetractedThe role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Self-citationSystematic Localization of Common Disease-Associated Variation in Regulatory DNA
Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Honda, K., & Taniguchi, T. (2006) · Nature Reviews Immunology · doi:10.1038/nri1900 · Cited by 1,676
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,517
Self-citationDemonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Viruses and interferon: a fight for supremacy
Katze, M. G., He, Y., & Gale, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri888 · Cited by 1,419
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C. F., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9212 · Cited by 1,402
Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors
Honda, K., Takaoka, A., & Taniguchi, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.009 · Cited by 1,393
The Molecular Cell Biology of Interferon-gamma and its Receptor
Farrar, M. A., & Schreiber, R. D. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003035 · Cited by 1,341
The IRF Family Transcription Factors in Immunity and Oncogenesis
Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259
Fuertes, M. B., Kacha, A. K., Kline, J., Woo, S.-R., Kranz, D. M., Murphy, K. M., & Gajewski, T. F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101159 · Cited by 1,192
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Self-citationType I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081
MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
Pamer, E., & Cresswell, P. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.323 · Cited by 1,008
CXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,001
Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15
Lucas, M., Schachterle, W., Oberle, K., Aichele, P., & Diefenbach, A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.006 · Cited by 887
INTERFEROME v2.0: an updated database of annotated interferon-regulated genes
Rusinova, I., Forster, S., Yu, S., Kannan, A., Masse, M., Cumming, H., Chapman, R., & Hertzog, P. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1215 · Cited by 878
Cole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2009 · Cited by 870
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
Goubau, D., Deddouche, S., & Reis e Sousa, C. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.007 · Cited by 843
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis
Chawla-Sarkar, M., Lindner, D. J., Liu, Y.-F., Williams, B. R., Sen, G. C., Silverman, R. H., & Borden, E. C. (2003) · Apoptosis · doi:10.1023/a:1023668705040 · Cited by 829
Self-citationSOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · STEM CELLS · doi:10.1634/stemcells.19-5-378 · Cited by 827
Aas, T., Børresen, A.-L., Geisler, S., Smith-Sørensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., & Lønning, P. E. (1996) · Nature Medicine · doi:10.1038/nm0796-811 · Cited by 736
Friedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M., & Stark, G. R. (1984) · Cell · doi:10.1016/0092-8674(84)90270-8 · Cited by 718
Self-citationRANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 717
Kirou, K. A., Lee, C., George, S., Louca, K., Peterson, M. G. E., & Crow, M. K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21031 · Cited by 701
Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649
Suppressors of cytokine signalling (SOCS) in the immune system
Alexander, W. S. (2002) · Nature Reviews Immunology · doi:10.1038/nri818 · Cited by 645
Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., & Belardelli, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1777 · Cited by 643
An Atomic Model of the Interferon-β Enhanceosome
Panne, D., Maniatis, T., & Harrison, S. C. (2007) · Cell · doi:10.1016/j.cell.2007.05.019 · Cited by 625
Weichselbaum, R. R., Ishwaran, H., Yoon, T., Nuyten, D. S. A., Baker, S. W., Khodarev, N., Su, A. W., Shaikh, A. Y., Roach, P., Kreike, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809242105 · Cited by 615
A critical function for type I interferons in cancer immunoediting
Dunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1213 · Cited by 605
Signals required for programming effector and memory development by CD8+ T cells
Mescher, M. F., Curtsinger, J. M., Agarwal, P., Casey, K. A., Gerner, M., Hammerbeck, C. D., Popescu, F., & Xiao, Z. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00382.x · Cited by 601
Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency
Bogunovic, D., Byun, M., Durfee, L. A., Abhyankar, A., Sanal, O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A. V., Adimi, P., et al. (2012) · Science · doi:10.1126/science.1224026 · Cited by 572
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Complex modulation of cell type-specific signaling in response to type I interferons
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.014 · Cited by 530
Self-citationDirect Effects of Type I Interferons on Cells of the Immune System
Hervas-Stubbs, S., Perez-Gracia, J. L., Rouzaut, A., Sanmamed, M. F., Le Bon, A., & Melero, I. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1114 · Cited by 503
Sidky, Y. A., & Borden, E. C. (1987) · PubMed · Cited by 494
Self-citationA weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483
Gehrke, N., Mertens, C., Zillinger, T., Wenzel, J., Bald, T., Zahn, S., Tüting, T., Hartmann, G., & Barchet, W. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.004 · Cited by 473
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.011 · Cited by 470
Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas
Hoek, K., Rimm, D. L., Williams, K. R., Zhao, H., Ariyan, S., Lin, A., Kluger, H. M., Berger, A. J., Cheng, E., Trombetta, E. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0731 · Cited by 448
Lee, S.-J., Jang, B.-C., Lee, S.-W., Yang, Y.-I., Suh, S.-I., Park, Y.-M., Oh, S., Shin, J.-G., Yao, S., Chen, L., et al. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.093 · Cited by 446
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines
Peng, W., Liu, C., Xu, C., Lou, Y., Chen, J., Yang, Y., Yagita, H., Overwijk, W. W., Lizée, G., Radvanyi, L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1187 · Cited by 432
Sato, T., Onai, N., Yoshihara, H., Arai, F., Suda, T., & Ohteki, T. (2009) · Nature Medicine · doi:10.1038/nm.1973 · Cited by 418
Expression profiling reveals novel pathways in the transformation of Melanocytes to Melanomas.
Hoek, K., Rimm, D., Williams, K., Zhao, H., Ariyan, S., Lin, A., Kluger, H., Berger, A., Cheng, E., Trombetta, E. S., et al. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00175_12.x · Cited by 412
Immunoregulatory properties of ISG15, an interferon-induced cytokine.
D'Cunha, J., Knight, E., Haas, A. L., Truitt, R. L., & Borden, E. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.211 · Cited by 383
Self-citationMühlbauer, M., Fleck, M., Schütz, C., Weiss, T., Froh, M., Blank, C., Schölmerich, J., & Hellerbrand, C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.007 · Cited by 378
The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Guo, B., Chang, E. Y., & Cheng, G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33342 · Cited by 371
Le Bon, A., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2074 · Cited by 361
Lethal anemia caused by interferon-β produced in mouse embryos carrying undigested DNA
Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H., & Nagata, S. (2005) · Nature Immunology · doi:10.1038/ni1146 · Cited by 359
Structure and Function of the Interferon- Enhanceosome
MANIATIS, T., FALVO, J. V., KIM, T. H., KIM, T. K., LIN, C. H., PAREKH, B. S., & WATHELET, M. G. (1998) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1998.63.609 · Cited by 358
Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Thomas, C., Moraga, I., Levin, D., Krutzik, P. O., Podoplelova, Y., Trejo, A., Lee, C., Yarden, G., Vleck, S. E., Glenn, J. S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.048 · Cited by 356
Interferon-Stimulated Gene 15 and the Protein ISGylation System
Zhang, D., & Zhang, D.-E. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0110 · Cited by 355
Kondo, T., Kobayashi, J., Saitoh, T., Maruyama, K., Ishii, K. J., Barber, G. N., Komatsu, K., Akira, S., & Kawai, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222694110 · Cited by 345
Protein degradation and the generation of MHC class I-presented peptides
Rock, K. L., York, I. A., Saric, T., & Goldberg, A. L. (2002) · Advances in Immunology · doi:10.1016/s0065-2776(02)80012-8 · Cited by 339
Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function
Swann, J. B., Hayakawa, Y., Zerafa, N., Sheehan, K. C. F., Scott, B., Schreiber, R. D., Hertzog, P., & Smyth, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7540 · Cited by 339
STING-dependent cytosolic DNA sensing pathways
Barber, G. N. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.010 · Cited by 336
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
Cheon, H., Holvey-Bates, E. G., Schoggins, J. W., Forster, S., Hertzog, P., Imanaka, N., Rice, C. M., Jackson, M. W., Junk, D. J., & Stark, G. R. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.203 · Cited by 334
Self-citationvon Marschall, Z., Scholz, A., Cramer, T., Schafer, G., Schirner, M., Oberg, K., Wiedenmann, B., Hocker, M., & Rosewicz, S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.437 · Cited by 328
Khodarev, N. N., Beckett, M., Labay, E., Darga, T., Roizman, B., & Weichselbaum, R. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308102100 · Cited by 326
Cross Talk Between Interferon-γ and -α/β Signaling Components in Caveolar Membrane Domains
Takaoka, A., Mitani, Y., Suemori, H., Sato, M., Yokochi, T., Noguchi, S., Tanaka, N., & Taniguchi, T. (2000) · Science · doi:10.1126/science.288.5475.2357 · Cited by 319
New Insights into the Role of RNase L in Innate Immunity
Chakrabarti, A., Jha, B. K., & Silverman, R. H. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0120 · Cited by 314
Fleetwood, A. J., Dinh, H., Cook, A. D., Hertzog, P. J., & Hamilton, J. A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1108702 · Cited by 312
Marfaing-Koka, A., Devergne, O., Gorgone, G., Portier, A., Schall, T. J., Galanaud, P., & Emilie, D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.4.1870 · Cited by 306
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases
Casey, G., Neville, P. J., Plummer, S. J., Xiang, Y., Krumroy, L. M., Klein, E. A., Catalona, W. J., Nupponen, N., Carpten, J. D., Trent, J. M., et al. (2002) · Nature Genetics · doi:10.1038/ng1021 · Cited by 305
Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes
Cheon, H., & Stark, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903487106 · Cited by 305
Self-citationProduction of type I interferons
Asselin-Paturel, C., & Trinchieri, G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051395 · Cited by 305
Identification of JAK/STAT signalling components by genome-wide RNA interference
Müller, P., Kuttenkeuler, D., Gesellchen, V., Zeidler, M. P., & Boutros, M. (2005) · Nature · doi:10.1038/nature03869 · Cited by 297
Interferon-γ links ultraviolet radiation to melanomagenesis in mice
Zaidi, M. R., Davis, S., Noonan, F. P., Graff-Cherry, C., Hawley, T. S., Walker, R. L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H. A., et al. (2011) · Nature · doi:10.1038/nature09666 · Cited by 293
Salaverria, I., Philipp, C., Oschlies, I., Kohler, C. W., Kreuz, M., Szczepanowski, M., Burkhardt, B., Trautmann, H., Gesk, S., Andrusiewicz, M., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330795 · Cited by 292
Yao, Y., Richman, L., Higgs, B. W., Morehouse, C. A., de los Reyes, M., Brohawn, P., Zhang, J., White, B., Coyle, A. J., Kiener, P. A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24557 · Cited by 284
Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection
Ritchie, K. J., Hahn, C. S., Kim, K. I., Yan, M., Rosario, D., Li, L., de la Torre, J. C., & Zhang, D.-E. (2004) · Nature Medicine · doi:10.1038/nm1133 · Cited by 278
Okabe, Y., Kawane, K., Akira, S., Taniguchi, T., & Nagata, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051654 · Cited by 275
Dinney, C. P., Bielenberg, D. R., Perrotte, P., Reich, R., Eve, B. Y., BUCANA, C. D., & Fidler, I. J. (1998) · PubMed · Cited by 271
Leonova, K. I., Brodsky, L., Lipchick, B., Pal, M., Novototskaya, L., Chenchik, A. A., Sen, G. C., Komarova, E. A., & Gudkov, A. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216922110 · Cited by 261
Transcriptional signaling by double-stranded RNA: role of TLR3
SEN, G., & SARKAR, S. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.006 · Cited by 258
Hida, S., Ogasawara, K., Sato, K., Abe, M., Takayanagi, H., Yokochi, T., Sato, T., Hirose, S., Shirai, T., Taki, S., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00064-9 · Cited by 251
A stress-responsive RNA switch regulates VEGFA expression
Ray, P. S., Jia, J., Yao, P., Majumder, M., Hatzoglou, M., & Fox, P. L. (2009) · Nature · doi:10.1038/nature07598 · Cited by 249
Rökman, A., Ikonen, T., Seppälä, E. H., Nupponen, N., Autio, V., Mononen, N., Bailey-Wilson, J., Trent, J., Carpten, J., Matikainen, M. P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340450 · Cited by 238
Proteomic identification of proteins conjugated to ISG15 in mouse and human cells
Giannakopoulos, N. V., Luo, J.-K., Papov, V., Zou, W., Lenschow, D. J., Jacobs, B. S., Borden, E. C., Li, J., Virgin, H. W., & Zhang, D.-E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.132 · Cited by 235
Self-citationFrasch, S. C., Henson, P. M., Kailey, J. M., Richter, D. A., Janes, M. S., Fadok, V. A., & Bratton, D. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003116200 · Cited by 234
Wong, L. H., Krauer, K. G., Hatzinisiriou, I., Estcourt, M. J., Hersey, P., Tam, N. D., Edmondson, S., Devenish, R. J., & Ralph, S. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28779 · Cited by 234
Piehler, J., Thomas, C., Garcia, K. C., & Schreiber, G. (2012) · Immunological Reviews · doi:10.1111/imr.12001 · Cited by 230
Emerging Role of ISG15 in Antiviral Immunity
Skaug, B., & Chen, Z. J. (2010) · Cell · doi:10.1016/j.cell.2010.09.033 · Cited by 222
Interferon induction and function at the mucosal surface
Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2013) · Immunological Reviews · doi:10.1111/imr.12101 · Cited by 220
Spontaneous Cell-Mediated Cytotoxicity in Humans: Role of Interferon and Immunoglobulins
Trinchieri, G., Santoli, D., & Koprowski, H. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.6.1849 · Cited by 213
Deletions of Interferon Genes in Acute Lymphoblastic Leukemia
Diaz, M. O., Rubin, C. M., Harden, A., Ziemin, S., Larson, R. A., Le Beau, M. M., & Rowley, J. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220202 · Cited by 211
Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b
Yurkovetsky, Z. R., Kirkwood, J. M., Edington, H. D., Marrangoni, A. M., Velikokhatnaya, L., Winans, M. T., Gorelik, E., & Lokshin, A. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1805 · Cited by 207
Mesa, R. A., Yasothan, U., & Kirkpatrick, P. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3652 · Cited by 200
Deficiency of the type I interferon receptor protects mice from experimental lupus
Nacionales, D. C., Kelly‐Scumpia, K. M., Lee, P. Y., Weinstein, J. S., Lyons, R., Sobel, E., Satoh, M., & Reeves, W. H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23023 · Cited by 194
Mini ReviewHuman Interferons Alpha, Beta and Omega
Bekisz, J., Schmeisser, H., Hernandez, J., Goldman, N. D., & Zoon, K. C. (2004) · Growth Factors · doi:10.1080/08977190400000833 · Cited by 194
Kotenko, S. V. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.007 · Cited by 193
JAK/STAT/SOCS‐signaling pathway and colon and rectal cancer
Slattery, M. L., Lundgreen, A., Kadlubar, S. A., Bondurant, K. L., & Wolff, R. K. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.21841 · Cited by 192
Review: IFN- α / β Receptor Interactions to Biologic Outcomes: Understanding the Circuitry
Brierley, M. M., & Fish, E. N. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002760274845 · Cited by 190
Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice
Mundy-Bosse, B. L., Lesinski, G. B., Jaime-Ramirez, A. C., Benninger, K., Khan, M., Kuppusamy, P., Guenterberg, K., Kondadasula, S. V., Chaudhury, A. R., La Perle, K. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2670 · Cited by 189
Guenzi, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.20.5568 · Cited by 188
IRF family proteins and type I interferon induction in dendritic cells
Tailor, P., Tamura, T., & Ozato, K. (2006) · Cell Research · doi:10.1038/sj.cr.7310018 · Cited by 186
Coro, E. S., Chang, W. L. W., & Baumgarth, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4343 · Cited by 182
Guenzi, E., Töpolt, K., Lubeseder–Martellato, C., Jörg, A., Naschberger, E., Benelli, R., Albini, A., & Stürzl, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg382 · Cited by 173
Interferons as Inducers of Apoptosis in Malignant Cells
Kotredes, K. P., & Gamero, A. M. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0110 · Cited by 171
Thomas, K. E., Galligan, C. L., Newman, R. D., Fish, E. N., & Vogel, S. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604958200 · Cited by 170
Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response
Schiavoni, G., Mattei, F., & Gabriele, L. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00483 · Cited by 169
Wu, T. R., Hong, Y. K., Wang, X.-D., Ling, M. Y., Dragoi, A. M., Chung, A. S., Campbell, A. G., Han, Z.-Y., Feng, G.-S., & Chin, Y. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207536200 · Cited by 169
Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells
Waddell, S. J., Popper, S. J., Rubins, K., Griffiths, M. J., Brown, P. O., Levin, M., & Relman, D. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009753 · Cited by 166
Cairns, P., Tokino, K., Eby, Y. J., & Sidransky, D. (1994) · PubMed · Cited by 163
Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections
Henry, T., Kirimanjeswara, G. S., Ruby, T., Jones, J. W., Peng, K., Perret, M., Ho, L., Sauer, J.-D., Iwakura, Y., Metzger, D. W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902065 · Cited by 162
Khodarev, N. N., Minn, A. J., Efimova, E. V., Darga, T. E., Labay, E., Beckett, M., Mauceri, H. J., Roizman, B., & Weichselbaum, R. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1019 · Cited by 161
Vestal, D. J., & Jeyaratnam, J. A. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0102 · Cited by 160
Epigenetic silencing of multiple interferon pathway genes after cellular immortalization
Kulaeva, O. I., Drăghici, S., Tang, L., Kraniak, J. M., Land, S. J., & Tainsky, M. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206594 · Cited by 154
Cheon, H., Yang, J. B., & Stark, G. R. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0100 · Cited by 153
Self-citationEmerging Roles of FAM14 Family Members (G1P3/ISG 6–16 and ISG12/IFI27) in Innate Immunity and Cancer
Cheriyath, V., Leaman, D. W., & Borden, E. C. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0105 · Cited by 152
Self-citationSystems Biology of Interferon Responses
Hertzog, P. J., Forster, S. C., & Samarajiwa, S. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0126 · Cited by 144
Olopade, O. I., Buchhagen, D. L., Malik, K., Sherman, J., Nobori, T., Bader, S. A., Nau, M. M., Gazdar, A. F., Minna, J. D., & Dı́az, M. O. (1993) · PubMed · Cited by 141
The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse
Lesinski, G. B., Anghelina, M. I., Zimmerer, J. M., Bakalakos, T., Badgwell, B. D., Parihar, R., Hu, Y., Becknell, B., Abood, G. J., Chaudhury, A. R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16603 · Cited by 139
Molecular Basis of DNA Recognition in the Immune System
Atianand, M., & Fitzgerald, K. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203162 · Cited by 138
Epigenetic Silencing of Interferon-κ in Human Papillomavirus Type 16–Positive Cells
Rincón‐Orozco, B., Halec, G., Rosenberger, S., Muschik, D., Nindl, I., Bachmann, A., Ritter, T. M., Dondog, B., Ly, R., Bosch, F. X., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0550 · Cited by 138
Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a
Rosebeck, S., & Leaman, D. W. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0190-0 · Cited by 134
Interferon messenger RNA is produced constitutively in the organs of normal individuals.
Tovey, M. G., Streuli, M., Gresser, I., Gugenheim, J., Blanchard, B., Guymarho, J., Vignaux, F., & Gigou, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5038 · Cited by 133
Duarte, C. W., Willey, C. D., Zhi, D., Cui, X., Harris, J. J., Vaughan, L. K., Mehta, T. S., McCubrey, R. O., Khodarev, N. N., Weichselbaum, R. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029653 · Cited by 133
Johnsen, A. K., France, J., Sy, M., & Harding, C. V. (1998) · PubMed · Cited by 131
Rennert, H., Bercovich, D., Hubert, A., Abeliovich, D., Rozovski, U., Bar‐Shira, A., Soloviov, S., Schreiber, L., Matzkin, H., Rennert, G., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342775 · Cited by 128
Recognition of cytosolic DNA by c GAS and other STING ‐dependent sensors
Bhat, N., & Fitzgerald, K. A. (2013) · European Journal of Immunology · doi:10.1002/eji.201344127 · Cited by 127
Wallace, T. A., Martin, D., & Ambs, S. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr066 · Cited by 126
Reu, F. J., Bae, S. I., Cherkassky, L., Leaman, D. W., Lindner, D. J., Beaulieu, N., MacLeod, A. R., & Borden, E. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4074 · Cited by 125
Self-citationSTAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy
Khodarev, N. N., Roach, P., Pitroda, S. P., Golden, D. W., Bhayani, M. K., Shao, M. Y., Darga, T. E., Beveridge, M. G., Sood, R. F., Sutton, H. G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005821 · Cited by 122
G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells
Cheriyath, V., Glaser, K. B., Waring, J. F., Baz, R., Hussein, M. A., & Borden, E. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31122 · Cited by 122
Self-citationConstitutive IFN-α/β Signal for Efficient IFN-α/β Gene Induction by Virus
Hata, N., Sato, M., Takaoka, A., Asagiri, M., Tanaka, N., & Taniguchi, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5159 · Cited by 121
Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis
Cai, D., Cao, J., Li, Z., Zheng, X., Yao, Y., Li, W., & Yuan, Z. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-102 · Cited by 118
Radvanyi, Banerjee, Weir, & Messner (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00625.x · Cited by 118
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival
Slattery, M. L., Lundgreen, A., Bondurant, K. L., & Wolff, R. K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr189 · Cited by 115
Potu, H., Sgorbissa, A., & Brancolini, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1942 · Cited by 113
Cho, H.-Y., Lee, S.-W., Seo, S., Choi, I., Choi, I., & Lee, S.-W. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.08.003 · Cited by 111
Belardelli, F., Gresser, I., Maury, C., & Maunoury, M. T. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910300621 · Cited by 111
Suomela, S., Cao, L. H., Bowcock, A. M., & Saarialho‐Kere, U. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22322.x · Cited by 110
Padovan, E., Terracciano, L., Certa, U., Jacobs, B., Reschner, A., Bolli, M., Spagnoli, G. C., Borden, E. C., & Heberer, M. (2002) · PubMed · Cited by 109
Self-citationBiologic Effects of Interferons
Gresser, I. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874776 · Cited by 109
Mitani, Y., Takaoka, A., Kim, S. H., Kato, Y. H., Yokochi, T., Tanaka, N., & Taniguchi, T. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00448.x · Cited by 108
Burchert, A., Cai, D., Hofbauer, L. C., Samuelsson, M. K. R., Slater, E. P., Duyster, J., Ritter, M., Hochhaus, A., Müller, R., Eilers, M., et al. (2003) · Blood · doi:10.1182/blood-2003-08-2970 · Cited by 108
Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development
Yamamoto, M., Kato, T., Hotta, C., Nishiyama, A., Kurotaki, D., Yoshinari, M., Takami, M., Ichino, M., Nakazawa, M., Matsuyama, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025812 · Cited by 105
Stochastic Receptor Expression Determines Cell Fate upon Interferon Treatment
Levin, D., Harari, D., & Schreiber, G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05251-11 · Cited by 105
Evasion of host immunity directed by papillomavirus-encoded proteins
O’Brien, P. M., & Campo, M. S. (2002) · Virus Research · doi:10.1016/s0168-1702(02)00123-5 · Cited by 104
Cheng, C. S., Feldman, K. E., Lee, J., Verma, S., Huang, D.-B., Huynh, K., Chang, M., Ponomarenko, J. V., Sun, S., Benedict, C. A., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001501 · Cited by 104
Hatano, H., Kudo, Y., Ogawa, I., Tsunematsu, T., Kikuchi, A., Abiko, Y., & Takata, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4761 · Cited by 101
Katsoulidis, E., Mavrommatis, E., Woodard, J., Shields, M. A., Sassano, A., Carayol, N., Sawicki, K. T., Munshi, H. G., & Platanias, L. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151076 · Cited by 95
Miller, J. C., Ma, Y., Bian, J., Sheehan, K. C. F., Zachary, J. F., Weis, J. H., Schreiber, R. D., & Weis, J. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8492 · Cited by 94
Guadagni, F., Schlom, J., Johnston, W. W., Szpak, C. A., Goldstein, D., Smalley, R., Simpson, J. F., Borden, E. C., Pestka, S., & Greiner, J. W. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.502 · Cited by 91
Self-citationŁuszczek, W., Cheriyath, V., Mekhail, T. M., & Borden, E. C. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0309 · Cited by 87
Self-citationZhou, Q., Zhao, J., Al-Zoghaibi, F., Zhou, A., Wiedmer, T., Silverman, R. H., & Sims, P. J. (2000) · Blood · doi:10.1182/blood.v95.8.2593 · Cited by 87
Gene Repression by Coactivator Repulsion
Senger, K., Merika, M., Agalioti, T., Yie, J., Escalante, C. R., Chen, G., Aggarwal, A. K., & Thanos, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00081-x · Cited by 84
Ezell, S. A., Polytarchou, C., Hatziapostolou, M., Guo, A., Sanidas, I., Bihani, T., Comb, M. J., Sourvinos, G., & Tsichlis, P. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115029109 · Cited by 84
Roles of interferon produced in physiological conditions. A speculative review.
Bocci, V. A. (1988) · PubMed · Cited by 84
The human interferon-gamma receptor. Purification, characterization, and preparation of antibodies.
Novick, D., Orchansky, P. L., Revel, M., & Rubinstein, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47439-x · Cited by 82
The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe?☆
Andersen, J. B., & HASSEL, B. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.10.001 · Cited by 82
Rickardson, L., Fryknäs, M., Dhar, S., Lövborg, H., Gullbo, J., Rydåker, M., Nygren, P., Gustafsson, M. G., Larsson, R., & Isaksson, A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602699 · Cited by 82
STAT1 in Peripheral Tissue Differentially Regulates Homing of Antigen-Specific Th1 and Th2 Cells
Mikhak, Z., Fleming, C. M., Medoff, B. D., Thomas, S. Y., Tager, A. M., Campanella, G. S. V., & Luster, A. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4959 · Cited by 79
Balachandran, S., & Beg, A. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002165 · Cited by 76
Kundu, S., Fan, K., Cao, M., Lindner, D. J., Zhao, Z. J., Borden, E. C., & Yi, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903562 · Cited by 74
Self-citationLai, K., Liu, C. J., Chang, K., & Lee, T. (2012) · Oncogene · doi:10.1038/onc.2012.384 · Cited by 72
Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs
Yi, T., Pathak, M. K., Lindner, D. J., Ketterer, M. E., Farver, C. F., & Borden, E. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5978 · Cited by 70
Self-citationSilverman, R. H., Halloum, A., Zhou, A., Dong, B., Al-Zoghaibi, F., Kushner, D. M., Zhou, Q., Zhao, J., Wiedmer, T., & Sims, P. J. (2002) · PubMed · Cited by 68
Bi, X., Hameed, M., Mirani, N. M., Pimenta, E. M., Anari, J. B., & Barnes, B. J. (2011) · Breast Cancer Research · doi:10.1186/bcr3053 · Cited by 68
Belardelli, F., Gresser, I., Maury, C., & Maunoury, M. T. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910300622 · Cited by 65
Toll-Like Receptors as Interferon-Regulated Genes and Their Role in Disease
Khoo, J. J., Forster, S. C., & Mansell, A. S. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0095 · Cited by 65
Zhang, L., & Pagano, J. S. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.341-350.2001 · Cited by 65
McCarty, M. F., Bielenberg, D. R., Donawho, C. K., Bucana, C. D., & Fidler, I. J. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1020923326441 · Cited by 64
IRF4 mutations in chronic lymphocytic leukemia
Havelange, V., Pekarsky, Y., Nakamura, T., Palamarchuk, A., Alder, H., Rassenti, L. Z., Kipps, T. J., & Croce, C. M. (2011) · Blood · doi:10.1182/blood-2011-04-350579 · Cited by 64
Chen, H., Tanaka, N., Mitani, Y., Oda, E., Nozawa, H., Chen, J., Yanai, H., Negishi, H., Choi, M. K., Iwasaki, T., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01051.x · Cited by 63
Park, B.-K. (2001) · Immune Network · doi:10.4110/in.2001.1.2.109 · Cited by 60
Interferon-β Prevents the Upregulation of Interleukin-8 Expression in Human Melanoma Cells
SINGH, R. K., Gutman, M., Llansa, N., & Fidler, I. J. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.577 · Cited by 60
Ravera, R., Gioia, D. M., Andrea, M. D., Cappello, P., Giovarelli, M., Marconi, P., Manservigi, R., Gariglio, M., & Landolfo, S. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.014 · Cited by 59
Hamilton, J. A., Whitty, G. A., Kola, I., & Hertzog, P. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2553 · Cited by 58
Inhibition of Tumor Cell Motility by the Interferon-inducible GTPase MxA
Mushinski, J. F., Nguyen, P., Stevens, L. M., Khanna, C., Lee, S., Chung, E. J., Lee, M.-J., Kim, Y. S., Linehan, W. M., Horisberger, M. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806324200 · Cited by 58
A Germline Variant in the Interferon Regulatory Factor 4 Gene as a Novel Skin Cancer Risk Locus
Han, J., Qureshi, A. A., Nan, H., Zhang, J., Song, Y., Guo, Q., & Hunter, D. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1818 · Cited by 57
SHP-2 Expression Negatively Regulates NK Cell Function
Purdy, A. K., & Campbell, K. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900088 · Cited by 55
Innate immune sensing of cancer: clues from an identified role for type I IFNs
Gajewski, T. F., Fuertes, M. B., & Woo, S. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1305-6 · Cited by 54
Chronic myeloid leukemia cells resistant to interferon-α lack STAT1 expression
Landolfo, S., Guarini, A. R., Riera, L., Gariglio, M., Gribaudo, G., Cignetti, A., Cordone, I., Montefusco, E., Mandelli, F., & Foà, R. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200004 · Cited by 54
Green, W., Slovak, M., Chen, I.-M., Pallavicini, M. G., Hecht, J., & Willman, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401596 · Cited by 54
Cheng, X., Liu, Y., Chu, H., & Kao, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340505 · Cited by 53
Interferon-Stimulated Genes and Their Protein Products: What and How?
Borden, E. C., & Williams, B. R. G. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0129 · Cited by 53
Self-citationUbp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling
Yan, M., Luo, J.-K., Ritchie, K. J., Sakai, I., Takeuchi, K., Ren, R., & Zhang, D. (2007) · Blood · doi:10.1182/blood-2006-07-033209 · Cited by 53
Cramer, L. A., Nelson, S. L., & Klemsz, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3190 · Cited by 52
Cited by
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
Type I interferons in anticancer immunity
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J., & Kroemer, G. (2015) · Nature Reviews Immunology · doi:10.1038/nri3845 · Cited by 1,305
Antitumour actions of interferons: implications for cancer therapy
Parker, B. S., Rautela, J., & Hertzog, P. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.14 · Cited by 907
Turning cold tumors into hot tumors by improving T-cell infiltration
Liu, Y.-T., & Sun, Z.-J. (2021) · Theranostics · doi:10.7150/thno.58390 · Cited by 827
Yang, R., Sun, L., Li, C.-F., Wang, Y.-H., Yao, J., Li, H., Yan, M., Chang, W.-C., Hsu, J.-M., Cha, J.-H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21099-2 · Cited by 632
Metadata
- Authors
- Cheon, H., Borden, E. C., & Stark, G. R.
- Venue
- Seminars in Oncology
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 41
- Issue
- 2
- Pages
- 156-173
- ISSN
- 0093-7754 (ISSN-L)
- OpenAlex
- W2128402485
- Cited by
- 255
- References
- 221
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.